From: Applications of carbon dots and its modified carbon dots in bone defect repair
Preparation method | Carbon dots type | Surface added functional groups | Size | Properties | Reference |
---|---|---|---|---|---|
Hydrothermal treatment | HAP-CDs | Hydroxyapatite | 20-30nm | Strong cell adhesion and alkaline phosphatase activity | [54] |
- | CG- CDs | Collagen-genipin | 6-10nm | Promote differentiation of BMSCs to chondrocytes and promote cartilage regeneration | [57] |
Hydrothermal cum co-precipitation | HAP-NCDs | Hydroxyapatite | 85-200nm | Increased expression of osteogenic-related transcription factor 2, alkaline phosphatase, and osteocalcin Increased bone density | [58] |
Microwave-assisted pyrolysis | MiR-CDs | MiR-2861, Ascorbic acid, PEI | ~2.5nm | Promotes osteogenic differentiation | [59] |
Hydrothermal treatment | Zn-CDs | Zn2+ | 5.25nm | Induce osteoblast differentiation | [60] |
Hydrothermal treatment | Zn-CDs | Zn2+ | 1.7-2.5nm | Promotes bone regeneration Has good osteogenic activity | [61] |
- | SMCC-CDs | Sulfosuccinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate (sulfo-SMCC) | 13-22nm | Promotes differentiation of bMSCs to chondrocytes Promotes cartilage regeneration in vivo | [62] |
Hydrothermal treatment | Fe-CDs | Super-paramagnetic iron oxide nanoparticles | 40-60nm | Promotes osteochondral differentiation | [63] |
Microwave-assisted | Ascorbic acid- CDs | Ascorbic acid | 2-3nm | Activate the PERK-eIF2α-ATF4 signaling pathway Increased BSP and OCN expression Promote pre-osteoblast differentiation and bone regeneration | [64] |
Hydrothermal treatment | M-CDs | Metformin | 3.76nm | Promotes bone marrow mesenchymal stem cells (BMSCs), alkaline phosphatase (ALP) activity, calcium deposition nodule formation, and expression of osteogenic genes and proteins | [65] |
Microwave | CS-NHA-CDs | Chitosan, Nano-hydroxyapatite | 5nm | Enhanced adhesion and osteogenic differentiation of rBMSCs, good antibacterial effect Promoted the formation of vascularized bone tissue | [56] |
Hydrothermal treatment | SPIC-CDs | SVVYGLR, PRGDSGYRGDS, IPP, CGGKVGKACCVPTKLSPISVLYK | 2.2-4.8nm | Stimulates osteoblast adhesion, proliferation and differentiation, and induces angiogenesis | [53] |
Hydrothermal treatment | Citric acid-CDs | Citric acid | - | Upregulate the expression of osteoblast gene markers ALP, RUNX2, OCN and BSP to promote matrix mineralization and thus promote osteogenic differentiation of rBMSCs | [55] |
Hydrothermal treatment | PCL-CP-CDs | PCL, captopril | ~10nm | Enhanced activity, adhesion, alkaline phosphatase activity and mineralization | [66] |
Hydrothermal treatment | PCL/PVA-TCP3-CDs | PCL, PVA, calcium phosphate | 5-7nm | Significantly increased alkaline phosphatase activity and cell proliferation rate | [67] |
Microwave-assisted hydrothermal treatment | WS2 HJS-CDs | Heterojunction, WS2 nanosheets | 9.3-11.9nm | Significantly promotes osteogenic differentiation and significantly upregulates the expression of bone-related genes | [68] |
Hydrothermal treatment | OH-CDs | Hydroxyl | 4nm | Scavenges free radical groups and promotes cell proliferation | [69] |
Hydrothermal treatment | AA-CDs | Adenosine, aspirin | 2-5nm | Induced differentiation of hBMSCs toward osteogenesis | [70] |
Hydrothermal treatment | PLA-CDs | PLA | 3-7nm | Promotes cell proliferation, increased bone mineralization, and increased osteogenic differentiation | [71] |
Microwave-assisted | p-CDs | Positive charge | 3.6-5.8nm | Enhance antibacterial effect | [72] |
Microwave-assisted | n-CDs | Negative charge | 1.7-4.1nm | Promote osteogenic differentiation | [72] |
Hydrothermal treatment | CDs | - | ~10nm | High affinity with bone | [73] |
Hydrothermal treatment | Mg-CDs | Mg2+ | Up to 39.8nm with increasing temperature | Increase alkaline phosphatase (ALP) activity Upregulate the expression of osteogenic-related genes: Runx2, OSX, Col1a1, OCN | [74] |
Hydrothermal treatment | BMP-2-CDs | BMP-2 | 7-10nm | Enhanced MG-63 cell biology and osteoinductive effects | [75] |
Hydrothermal treatment | 2-CDs | 2-citric acid, poly (ethylene glycol) monomethyl ether (MW 550 Da), N, N-dimethylethylenediamine | 16.8-18.6nm | Promotes cell proliferation (transforming growth factor-β) and cartilage matrix deposition (glycosaminoglycan, type II collagen); Inhibits undesirable type I and type X collagen deposition | [76] |